Ameriprise’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-424,071
| Closed | -$1.44M | – | 3847 |
|
|
2018
Q3 | $1.44M | Buy |
424,071
+117,940
| +39% | +$425K | ﹤0.01% | 2936 |
|
|
2018
Q2 | $1.15M | Sell |
306,131
-811,186
| -73% | -$3.95M | ﹤0.01% | 2962 |
|
|
2018
Q1 | $4.57M | Sell |
1,117,317
-356,475
| -24% | -$1.66M | ﹤0.01% | 2233 |
|
|
2017
Q4 | $6.86M | Buy |
1,473,792
+435,835
| +42% | +$2.4M | ﹤0.01% | 1901 |
|
|
2017
Q3 | $7.37M | Sell |
1,037,957
-131,815
| -11% | -$948K | ﹤0.01% | 1801 |
|
|
2017
Q2 | $8.46M | Sell |
1,169,772
-466,729
| -29% | -$2.92M | ﹤0.01% | 1695 |
|
|
2017
Q1 | $10.1M | Sell |
1,636,501
-185,288
| -10% | -$1.02M | 0.01% | 1512 |
|
|
2016
Q4 | $10.7M | Sell |
1,821,789
-95,854
| -5% | -$524K | 0.01% | 1473 |
|
|
2016
Q3 | $10.2M | Buy |
1,917,643
+353,444
| +23% | +$1.91M | 0.01% | 1435 |
|
|
2016
Q2 | $10.4M | Sell |
1,564,199
-77,275
| -5% | -$432K | 0.01% | 1356 |
|
|
2016
Q1 | $7.66M | Sell |
1,641,474
-58,440
| -3% | -$233K | ﹤0.01% | 1642 |
|
|
2015
Q4 | $8.58M | Buy |
1,699,914
+1,526,094
| +878% | +$7.25M | 0.01% | 1562 |
|
|
2015
Q3 | $612K | Sell |
173,820
-82,231
| -32% | -$551K | ﹤0.01% | 3173 |
|
|
2015
Q2 | $2.56M | Buy |
256,051
+34,872
| +16% | +$374K | ﹤0.01% | 2591 |
|
|
2015
Q1 | $2.82M | Sell |
221,179
-252,085
| -53% | -$3.24M | ﹤0.01% | 2415 |
|
|
2014
Q4 | $6.7M | Buy |
473,264
+75,691
| +19% | +$1.17M | ﹤0.01% | 1857 |
|
|
2014
Q3 | $5.47M | Sell |
397,573
-278,015
| -41% | -$4.26M | ﹤0.01% | 1971 |
|
|
2014
Q2 | $10.4M | Sell |
675,588
-332,584
| -33% | -$4.71M | 0.01% | 1501 |
|
|
2014
Q1 | $17.2M | Sell |
1,008,172
-327,014
| -24% | -$4.93M | 0.01% | 1114 |
|
|
2013
Q4 | $17.3M | Sell |
1,335,186
-939,126
| -41% | -$11.2M | 0.01% | 1102 |
|
|
2013
Q3 | $23M | Buy |
2,274,312
+1,311,333
| +136% | +$11.7M | 0.02% | 921 |
|
|
2013
Q2 | $7.19M | Buy |
+962,979
| New | +$7.52M | 0.01% | 1647 |
|
Ameriprise's KERX Position: Q4 2018 in Review
Ameriprise sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 424,071 shares — an estimated $1.44M sold.
Ameriprise first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $23M in Q3 2013. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Ameriprise reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Ameriprise sold 424,071 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $1.44M.
- Ameriprise first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
- Ameriprise's Keryx Biopharmaceuticals Inc position peaked at $23M in Q3 2013.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Ameriprise's 13F filing for Q4 2018, filed 14 Feb 2019.